Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases
BERWYN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company addressing Alzheimer’s, Parkinson’s and other neurodegenerative diseases, was issued a patent (US 10,383,851) in August 2019 for …
Read More